Skip to content

Equistasi and Gait in Hemiparesis

Efficacy of Equistasi on the Gait of Patients Affected by Hemiparesis Due to Cerebrovascular Accident

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02714478
Enrollment
50
Registered
2016-03-21
Start date
2015-04-30
Completion date
Unknown
Last updated
2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis

Brief summary

The purpose of the study is to evaluate the effect of Equistasi device on quantitative and qualitative gait characteristics in patients affected by hemiparesis.

Interventions

DEVICEequistasi

3 devices will be placed in each patient: 1 at the spinosus process of L5; 1 at the insertion of transverse abdominis; 1 at the insertion of the gluteus medius to the femur. The devices will be kept for 55 minutes, during standard Physiotherapy

DEVICEplacebo

3 devices will be placed in each patient: 1 at the spinosus process of L5; 1 at the insertion of transverse abdominis; 1 at the insertion of the gluteus medius to the femur. The devices will be kept for 55 minutes, during standard Physiotherapy

Sponsors

Ospedale Generale Di Zona Moriggia-Pelascini
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* subacute hemiparesis * Functional Ambulation Classification \<4

Exclusion criteria

* previous neurological deficits * Glasgow Coma Scale \<13 * Complete sensory deficit in the lower limbs * Levels of Cognitive Functioning ≤5 * polyneuropathy * contraindications to mobilization/verticalization

Design outcomes

Primary

MeasureTime frame
disability change assessed using Functional Independence Measure scale0. 30. 60. 120 days
balance change assessed using Berg Balance Scale0. 30. 60. 120 days
gait pattern change assessed using Functional Ambulation Classification scale0. 30. 60. 120 days
gait speed change assessed using Timed Up and Go scale0. 30. 60. 120 days
gait pattern change using Tinetti scale for gait0. 30. 60. 120 days
gait speed change assessed using 10 meter walking test scale0. 30. 60. 120 days
swaying of the center of gravity change assessed with stabilometric platform indexes0. 30. 60. 120 days

Countries

Italy

Contacts

Primary ContactGiuseppe Frazzitta, MD
frazzittag62@gmail.com+39033492705

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026